212 related articles for article (PubMed ID: 34833377)
1. COVID-19 and Alzheimer's Disease: A Literature Review.
Hardan L; Filtchev D; Kassem R; Bourgi R; Lukomska-Szymanska M; Tarhini H; Salloum-Yared F; Mancino D; Kharouf N; Haikel Y
Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833377
[TBL] [Abstract][Full Text] [Related]
2. Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.
Naughton SX; Raval U; Pasinetti GM
J Alzheimers Dis; 2020; 76(1):21-25. PubMed ID: 32538855
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.
Amadoro G; Latina V; Stigliano E; Micera A
Cells; 2023 Nov; 12(22):. PubMed ID: 37998336
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
Chiricosta L; Gugliandolo A; Mazzon E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
[TBL] [Abstract][Full Text] [Related]
5. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
6. The interference between SARS-COV-2 and Alzheimer's disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic.
Mansour HM
Ageing Res Rev; 2024 Feb; 94():102195. PubMed ID: 38244862
[TBL] [Abstract][Full Text] [Related]
7. The Neuropathological Impacts of COVID-19: Challenges and Alternative Treatment Options for Alzheimer's Like Brain Changes on Severely SARS-CoV-2 Infected Patients.
Rahman MR; Akter R; Neelotpol S; Mayesha II; Afrose A
Am J Alzheimers Dis Other Demen; 2023; 38():15333175231214974. PubMed ID: 37972355
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 and Alzheimer's disease: how one crisis worsens the other.
Xia X; Wang Y; Zheng J
Transl Neurodegener; 2021 Apr; 10(1):15. PubMed ID: 33941272
[TBL] [Abstract][Full Text] [Related]
9. Can healthy lifestyle reduce disease progression of Alzheimer's during a global pandemic of COVID-19?
John A; Ali K; Marsh H; Reddy PH
Ageing Res Rev; 2021 Sep; 70():101406. PubMed ID: 34242809
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures.
Wang H; Lu J; Zhao X; Qin R; Song K; Xu Y; Zhang J; Chen Y
Neurol Sci; 2021 Dec; 42(12):4913-4920. PubMed ID: 34550494
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric Symptoms in Patients With Alzheimer's Disease During SARS-COV-2 Pandemic in Peru.
Custodio N; Castro-Suárez S; Montesinos R; Failoc-Rojas VE; Cruz Del Castillo R; Herrera-Perez E
Am J Alzheimers Dis Other Demen; 2021; 36():15333175211039089. PubMed ID: 34416114
[TBL] [Abstract][Full Text] [Related]
12. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
Huang P; Zhang LY; Tan YY; Chen SD
Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
[TBL] [Abstract][Full Text] [Related]
13. Association of Alzheimer's Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study.
Chung SJ; Chang Y; Jeon J; Shin JI; Song TJ; Kim J
J Alzheimers Dis; 2022; 87(2):701-710. PubMed ID: 35275548
[TBL] [Abstract][Full Text] [Related]
14. Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease.
Sood A; Goyal R; Singh H; Behl T; Arora S; Saini B; Kaur R
CNS Neurol Disord Drug Targets; 2022; 21(3):235-245. PubMed ID: 34414876
[TBL] [Abstract][Full Text] [Related]
15. Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer's Disease.
Kosenko E; Tikhonova L; Alilova G; Montoliu C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982809
[TBL] [Abstract][Full Text] [Related]
16. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.
Calderón-Garcidueñas L; Torres-Jardón R; Franco-Lira M; Kulesza R; González-Maciel A; Reynoso-Robles R; Brito-Aguilar R; García-Arreola B; Revueltas-Ficachi P; Barrera-Velázquez JA; García-Alonso G; García-Rojas E; Mukherjee PS; Delgado-Chávez R
J Alzheimers Dis; 2020; 78(2):479-503. PubMed ID: 32955466
[TBL] [Abstract][Full Text] [Related]
17. The relationship of early- and late-onset Alzheimer's disease genes with COVID-19.
Sirin S; Nigdelioglu Dolanbay S; Aslim B
J Neural Transm (Vienna); 2022 Jul; 129(7):847-859. PubMed ID: 35429259
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 as a Risk Factor for Alzheimer's Disease.
Golzari-Sorkheh M; Weaver DF; Reed MA
J Alzheimers Dis; 2023; 91(1):1-23. PubMed ID: 36314211
[TBL] [Abstract][Full Text] [Related]
19. Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease.
Lim KH; Yang S; Kim SH; Joo JY
J Infect; 2020 Sep; 81(3):e33-e34. PubMed ID: 32619698
[No Abstract] [Full Text] [Related]
20. Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection.
Danta CC
ACS Chem Neurosci; 2020 Aug; 11(15):2145-2148. PubMed ID: 32662982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
